4.8 Article

Regulation of ceramide biosynthesis by TOR complex 2

Journal

CELL METABOLISM
Volume 7, Issue 2, Pages 148-158

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2007.11.015

Keywords

-

Funding

  1. NIEHS NIH HHS [P30 ES05707, R37 ES02710, P30 ES005707, T32 ES007059, P42 ES004699, R37 ES002710] Funding Source: Medline
  2. NIGMS NIH HHS [R01 GM086387] Funding Source: Medline

Ask authors/readers for more resources

Ceramides and sphingoid long-chain bases (LCBs) are precursors to more complex sphingolipids; and play distinct signaling roles crucial for cell growth and survival. Conserved reactions within the sphingolipid biosynthetic pathway are responsible for the formation of these intermediates. Components of target of rapamycin complex 2 (TORC2) have been implicated in the biosynthesis of sphingolipids; in S. cerevisiae; however, the precise step regulated by this complex remains unknown. Here we demonstrate that yeast cells deficient in TORC2 activity are impaired for de novo ceramide biosynthesis both in vivo and in vitro. We find that TORC2 regulates this step in part by activating the AGC kinase Ypk2 and that this step is antagonized by the Ca2+/calmodulin-dependent phosphatase calcineurin. Because Ypk2 is activated independently by LCBs, the direct precursors to ceramides, our data suggest a model wherein TORC2 signaling is coupled with LCB levels to control Ypk2 activity and, ultimately, regulate ceramide formation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available